Officer files intent to sell $4.8M in Edgewise Therapeutics shares

summarizeSummary

An officer at Edgewise Therapeutics has filed a Form 144 to sell approximately $4.8 million in shares, continuing a pattern of significant insider selling.

check_boxKey Events

• Officer Files Intent to Sell

  Robert Michael Carruthers, an Officer of Edgewise Therapeutics, Inc., has filed a Form 144 indicating an intent to sell shares.

• Proposed Sale Value

  The filing details a proposed sale of 180,872 shares of common stock, with an approximate market value of $4,804,322.06.

• Recent Selling Activity

  This proposed sale follows previous sales by the same officer totaling 186,665 shares for gross proceeds of $4,606,397.57 over the past three months.

• Shares Acquired via Options

  The shares intended for sale were acquired through the exercise of options under a registered plan.

auto_awesomeAnalysis

Robert Michael Carruthers, an Officer at Edgewise Therapeutics, has filed a Form 144 indicating an intent to sell 180,872 shares of common stock, valued at approximately $4.8 million. This proposed sale follows recent sales by the same officer totaling $4.6 million over the past three months, suggesting a pattern of significant insider selling. While the proposed sale represents a relatively small percentage of the company's market capitalization, the cumulative value of these transactions from an officer could be interpreted negatively by investors.